Barriers to routine G6PD testing prior to treatment with primaquine

Barriers to routine G6PD testing prior to treatment with primaquine

Abstract Background Primaquine is essential for the radical cure of vivax malaria, however its broad application is hindered by the risk of drug-induced haemolysis in individuals with glucose-6-phosphate-dehydrogenase (G6PD) deficiency. Rapid diagnostic tests capable of diagnosing G6PD deficiency ar...

Full description

Bibliographic Details
Main Authors: Benedikt Ley, Kamala Thriemer, Jessica Jaswal, Eugenie Poirot, Mohammad Shafiul Alam, Ching Swe Phru, Wasif Ali Khan, Lek Dysoley, Gao Qi, Chong Chee Kheong, Ummi Kalthom Shamsudin, Ingrid Chen, Jimee Hwang, Roly Gosling, Ric N. Price
Format: Article
Language:English
Published: BMC 2017-08-01
Series:Malaria Journal
Online Access:http://link.springer.com/article/10.1186/s12936-017-1981-y

Internet

http://link.springer.com/article/10.1186/s12936-017-1981-y

Similar Items